Find a Physician

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Clinical Services

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Health Information

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Research and Clinical Trials

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

For Patients, Families & Visitors

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Professionals

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Hospital News

Return to Angela Kadenhe-Chiweshe, MD Overview

More on Angela Kadenhe-Chiweshe, MD

Angela Kadenhe-Chiweshe, MD

Dr. Kadenhe-Chiweshe completed her M.D. degree at the Pennsylvania State University College of Medicine. She entered a categorical general surgery residency at the University of Rochester where her interest in pediatric surgery was solidified. In 2001 she joined the Tumor Angiogenesis Research Laboratory run by Jessica Kandel and Darrell Yamashiro as a postdoctoral research fellow. She spent her time studying the effects of anti-angiogenic therapy in a xenograft model of hepatoblastoma. This work led to key discoveries of how this tumor responds to anti-angiogenic therapy. During this time she also completed an attenuated clinical fellowship in Extra-Corporal Membrane Oxygenation with Charles Stolar. She went on to complete her general surgery training at Columbia University in 2007, followed by a fellowship in Pediatric Surgery at the Children's Hospital of New York in 2009.

Dr. Kadenhe-Chiweshe joined the faculty of the College of Physicians and Surgeons, Columbia University, as Assistant Professor of Surgery in July 2009. Her clinical interest is all general pediatric surgery, in particular neonatal anomalies, minimal access surgery, and pediatric cancer.

Dr. Kadenhe-Chiweshe's academic interests are in the field of basic science research. She continues to study the effects of angiogenic therapies in hepatoblastoma xenografts, with emphasis on understanding the emergence of resistance to these therapies and the mechanisms that govern it.

Contact

Dr. Angela Kadenhe-Chiweshe
Directions
(212) 342-8586
  • Bookmark
  • Print


Top of page